National Bank of Canada’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-222,870
Closed -$517K 3217
2025
Q2
$517K Buy
222,870
+25,802
+13% +$63.2K ﹤0.01% 1401
2025
Q1
$282K Buy
197,068
+4,938
+3% +$8.25K ﹤0.01% 1451
2024
Q4
$351K Buy
192,130
+5,315
+3% +$7.22K ﹤0.01% 1497
2024
Q3
$232K Buy
186,815
+42,435
+29% +$57.5K ﹤0.01% 1353
2024
Q2
$198K Sell
144,380
-1,390
-1% -$1.84K ﹤0.01% 1353
2024
Q1
$177K Buy
145,770
+32,392
+29% +$52K ﹤0.01% 1442
2023
Q4
$191K Buy
113,378
+44,825
+65% +$67.6K ﹤0.01% 1447
2023
Q3
$137K Buy
+68,553
New +$147K ﹤0.01% 1563

Other funds holding THTX

National Bank of Canada's THTX Position: Q3 2025 in Review

National Bank of Canada sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 222,870 shares — an estimated $517K sold.

National Bank of Canada first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $517K in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • National Bank of Canada reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 222,870 Theratechnologies shares in Q3 2025, an estimated $517K.
  • National Bank of Canada first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • National Bank of Canada's Theratechnologies position peaked at $517K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.